Protecting a blockbuster diabetes treatment for AstraZeneca
AstraZeneca AB
Major victories across IP venues for Volkswagen, Audi, Bentley, and Lamborghini
Audi AG; Audi of America, LLC; Automobili Lamborghini America, LLC; Automobili Lamborghini S.p.A.; Bentley Motors Limited; Bentley Motors, Inc; Volkswagen AG; Volkswagen Group of America, Inc.
No confusion in trademark victory on summary judgment for the American Retirement Association
American Retirement Association
Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million
Intellia Therapeutics, Inc.
Finnegan secures favorable ITC ruling related to innovative electric SUVs for BMW
BMW of North America, LLC and Bayerische Motoren Werke AG
Finnegan fights for Sony’s “exceedingly famous” mark
Sony Group Corporation
Experience
Bial - Portela & CA S.A. v. Alkem Laboratories Ltd et al. Bial - Portela & CA S.A. v. Alkem Laboratories Ltd et al.
1:18-cv-00304, D. Del., Judges Connolly, Burke
Experience
Horizon Pharma v. Dr. Reddy's Laboratories, et al. Horizon Pharma v. Dr. Reddy's Laboratories, et al.
3:11-cv-02317, 3:11-cv-04275, 3:13-cv-00091, 3:13-cv-04022, D.N.J., Judge Cooper
17-2473, -2481, -2484, -2486, -2487, -2488, -2489, -2491, -2491, -2493, Fed. Cir.
Experience
Biogen International GmbH v. Teva Pharmaceuticals USA, Inc. Biogen International GmbH v. Teva Pharmaceuticals USA, Inc.
1:17-cv-00829, D. Del., Judge Noreika
1:17-cv-00116, N.D.W. Va., Judge Keeley
Experience
Ferring B.V. v. Allergan, Inc. Ferring B.V. v. Allergan, Inc.
1:12-cv-02650, S.D.N.Y., Judges Cott, Sweet
Experience
Otsuka Pharmaceutical Co., Ltd. v. Apotex Corp. Otsuka Pharmaceutical Co., Ltd. v. Apotex Corp.
1:14-cv-01078, -04671, -02982, -07405, -05878, -06398 -08074 -03306, -06890, -05876, -08077, -03168, -07252, -07105 -05537, -03996, -06158, -04508, -04307, -06397, -07106, -01979, -03445; 1:15-cv-0161, -07584, -01585, -07803, -08830, -05109, -07802, -08955, -01716, -01967, -06353, -08305; 1:16-cv-05288, -05400, -05949, -07705 -02475, -02476, -08284, -05743, -00086, -08085, -00555, -00557, -07346, -06067, -00405, -00424, -05688, -09603; 1:17-cv-02754, -00392, D.N.J., Judges Simandle, Williams
Experience
Ferring B.V. v. Watson Laboratories, Inc. Ferring B.V. v. Watson Laboratories, Inc.
3:11-cv-00481, D. Nev., Judges Cooke, Jones, McKibben
2:15-cv-04222, D.N.J., Judges Chesler, Hayden, Waldor
Experience
Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc. Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc.
1:04-cv-03521, D. Md., Judges Bennett, Quarles, Sullivan
14-1671, Fed. Cir., Judges Prost, Lourie, Gilstrap
17-1033, Fed. Cir., Judges Prost, Lourie, Taranto
Experience
Glenmark Generics Ltd. v. Ferring B.V. Glenmark Generics Ltd. v. Ferring B.V.
3:14-cv-00422, E.D. Va., Judge Hudson
Experience
Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals USA, Inc. Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals USA, Inc.
3:08-cv-01583, D.N.J., Judges Cooper, Goodman, Hughes
Experience
Acorda Therapeutics, Inc. v. Apotex Inc. Acorda Therapeutics, Inc. v. Apotex Inc.
2:07-cv-04937, D.N.J., Judges Arleo, Brown, Greenaway
12-1019, Fed. Cir., Judges Lourie, Prost, Wallach
Experience
Pronova Biopharma Norge AS v. Teva Pharmaceuticals USA, Inc. Pronova Biopharma Norge AS v. Teva Pharmaceuticals USA, Inc.
1:09-cv-00286, 1:10-cv-00800, D. Del., Judges Farnan, Robinson, Thynge
12-1498, -1499, Fed. Cir., Judges Dyk, O'Malley, Wallach
Experience
Elan Pharmaceuticals, Inc. v. Eon Labs, Inc. Elan Pharmaceuticals, Inc. v. Eon Labs, Inc.
1:04-cv-05540, E.D.N.Y., Judges Mauskopf, Trager, Mann
09-1437, -1438, Fed. Cir., Judges Bryson, Gajarsa, Prost
11-1070, Fed. Cir., Judges Newman, Rader, Reyna
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.